Stockscreener 앱 받기
3.34
6.03%
0.19
시간 외 거래:
3.34
전일 마감가:
$3.15
열려 있는:
$3.19
하루 거래량:
279.58K
Relative Volume:
1.43
시가총액:
$115.86M
수익:
-
순이익/손실:
$-32.94M
주가수익비율:
-3.009
EPS:
-1.11
순현금흐름:
$-24.95M
1주 성능:
+12.46%
1개월 성능:
+38.02%
6개월 성능:
-24.26%
1년 성능:
-37.45%
1일 변동 폭
$3.1006
$3.4188
1주일 범위
$2.89
$3.4188
52주 변동 폭
$1.84
$5.58
Achieve Life Sciences Inc Stock (ACHV) Company Profile
명칭
Achieve Life Sciences Inc
전화
425-686-1500
주소
22722 29TH DR. SE, SEATTLE, BC
ACHV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
3.34 | 103.01M | 0 | -32.94M | -24.95M | -1.11 |
|
ONC
Beone Medicines Ltd Adr
|
246.68 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.09 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.30 | 40.37M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.39 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
77.49 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-14 | 개시 | Rodman & Renshaw | Buy |
| 2024-09-27 | 개시 | Raymond James | Strong Buy |
| 2023-05-10 | 재확인 | Maxim Group | Buy |
| 2021-06-23 | 개시 | Oppenheimer | Outperform |
Achieve Life Sciences Inc 주식(ACHV)의 최신 뉴스
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference - GlobeNewswire
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Shares Purchased by Northern Trust Corp - Defense World
Shay Capital LLC Sells 425,000 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat
ACHV: New Insights from ORCA-3 Study to Be Shared at 2025 Conference | ACHV Stock News - GuruFocus
Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake | ACHV Stock News - GuruFocus
Achieve Life Sciences to Present Phase 3 Study Findings on Cytisinicline for Smoking Cessation at 2025 ATS Conference - Nasdaq
Achieve Life Sciences to Present New Data at the 2025 ATS - GlobeNewswire
New Clinical Data Shows Cytisinicline Cuts Nicotine Cravings in Phase 3 Trial | ACHV Stock News - Stock Titan
Brokers Offer Predictions for ACHV Q3 Earnings - Defense World
Tower Research Capital LLC TRC Acquires 4,905 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
What is Zacks Small Cap’s Estimate for ACHV Q2 Earnings? - Defense World
Achieve Life Sciences targets NDA submission for cytisinicline in June 2025 as open label study hits key milestones - MSN
Raymond James Financial Inc. Purchases New Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2025 Earnings Call Transcript - Insider Monkey
ACHV: Kicking Butts to Achieve June NDA Filing - Yahoo Finance
Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus
Earnings call transcript: Achieve Life Sciences Q1 2025 targets nicotine dependence market - Investing.com Nigeria
Earnings call transcript: Achieve Life Sciences Q1 2025 targets nicotine dependence market By Investing.com - Investing.com South Africa
Transcript : Achieve Life Sciences, Inc., Q1 2025 Earnings Call, May 13, 2025 - marketscreener.com
ACHV Prepares for FDA Submission of New Smoking Cessation Drug | - GuruFocus
Achieve Life Sciences Inc Reports Q1 2025 EPS of -$0.37, Aligns with Estimates; Revenue Remains at $0 Million - GuruFocus
ACHIEVE LIFE SCIENCES Earnings Results: $ACHV Reports Quarterly Earnings - Nasdaq
Achieve Life Sciences Reports First Quarter 2025 Financial Resul - GuruFocus
Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program - The Manila Times
Achieve Life Sciences Inc. Q1 Loss Increases In Line With Estimates - Nasdaq
ACHIEVE LIFE SCIENCES, INC. SEC 10-Q Report - TradingView
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Shares Bought by Barclays PLC - Defense World
Raymond James Financial Inc. Takes $554,000 Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Wells Fargo & Company MN Boosts Holdings in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Renaissance Technologies LLC Increases Stock Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Achieve Life Sciences (ACHV) to Release Quarterly Earnings on Thursday - MarketBeat
Will Cytisinicline Achieve The Long-Awaited Breakthrough In Nicotine Addiction Treatment? - RTTNews
Achieve Life Sciences to Announce First Quarter 2025 Financial R - GuruFocus
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 | ACHV Stock News - GuruFocus
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 - The Manila Times
Achieve Life Sciences to Announce First Quarter 2025 - GlobeNewswire
Achieve Life Sciences to Report Q1 Earnings: Latest Updates on Smoking Cessation Drug Development - Stock Titan
Achieve Life Sciences Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
JPMorgan Chase & Co. Buys 44,311 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Will the FDA approve the first new drug to help people quit smoking in 20 years? - statnews.com
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Stock Position Boosted by Geode Capital Management LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Here are Rogue Funds Updates on Achieve Life Sciences (ACHV) - MSN
LPL Financial LLC Has $693,000 Stock Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
LPL Financial LLC Acquires 5,500 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - The AM Reporter
Achieve Life Sciences announces publication of results from Phase 3 ORCA-3 trial - Yahoo Finance
Cytisinicline shows promise for smoking cessation By Investing.com - Investing.com Canada
Achieve Life Sciences Inc (ACHV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.95%
자본화:
|
볼륨(24시간):